- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (129)
- Timeline of Article Publication (1)
- Authors Evaluation (2)
- Article Quality Tracking (2)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5452)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2023 (publication date) through Jun 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: Past, current, and future. World J Hepatol 2023; 15(6): 755-774 [PMID: 37397931 DOI: 10.4254/wjh.v15.i6.755] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i6/755.htm |
| Number | Citing Articles |
| 1 |
Joey A. Muns, Erik Schooten, Rychon D. J. van Dasselaar, Yvet E. Noordman, Kevin Adamzek, Arthur C. Eibergen, Sebas D. Pronk, Sagel Cali, Niels J. Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen, R. Bart Takkenberg, Joanne Verheij, Stan F.J. van de Graaf, Bart A. Nijmeijer, Guus A.M.S. van Dongen. Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β. European Journal of Nuclear Medicine and Molecular Imaging 2024; doi: 10.1007/s00259-024-06785-9
|
| 2 |
Girish L. Gupte, Anshu Srivastava. Chronic Liver Disease in Children: From Diagnosis to Liver Transplantation. Indian Journal of Pediatrics 2024; 91(3): 260 doi: 10.1007/s12098-024-05030-3
|
| 3 |
Peng Ji, Yan Li, Zihan Wang, Siyu Jia, Xinyi Jiang, Hui Chen, Qun Wang. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications. Biomedicine & Pharmacotherapy 2024; 177: 117003 doi: 10.1016/j.biopha.2024.117003
|
| 4 |
Arndt Vogel, Robert C. Grant, Tim Meyer, Gonzalo Sapisochin, Grainne M. O’Kane, Anna Saborowski. Adjuvant and neoadjuvant therapies for hepatocellular carcinoma. Hepatology 2023; doi: 10.1097/HEP.0000000000000726
|
| 5 |
Man Na, Xingbiao Yang, Yongkun Deng, Zhaoheng Yin, Mingwei Li. Endoplasmic reticulum stress in the pathogenesis of alcoholic liver disease. PeerJ 2023; 11: e16398 doi: 10.7717/peerj.16398
|
| 6 |
Ming Yang, Chun-Ye Zhang. Interleukins in liver disease treatment. World Journal of Hepatology 2024; 16(2): 140-145 doi: 10.4254/wjh.v16.i2.140
Abstract(172) |
Core Tip(127) |
Full Article(HTML)(1348)
|
Full Article with Cover (PDF)-881K(38)
|
Full Article (Word)-128K(9)
|
Audio-129K(0)
|
Peer-Review Report-180K(19)
|
Answering Reviewers-111K(17)
|
Full Article (PDF)-371K(48)
|
Full Article (XML)-84K(23)
|
Times Cited (0)
|
Total Visits (2223)
|
Open
|
| 7 |
SayedH. Seif el-Din, OlfatA. Hammam, ShahiraM. Ezzat, Samira Saleh, MarwaM. Safar, WalaaH. El-Maadawy, NaglaaM. El-Lakkany. Hydroxysafflor yellow A protects against thioacetamide-induced liver fibrosis in rats via suppressing proinflammatory/fibrogenic mediators and promoting hepatic stellate cell senescence and apoptosis. Asian Pacific Journal of Tropical Biomedicine 2023; 13(8): 348 doi: 10.4103/2221-1691.383689
|
| 8 |
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2): 272 doi: 10.3390/life14020272
|
| 9 |
Tamer A. Addissouky, Majeed M. A. Ali, Ibrahim El Tantawy El Sayed, Yuliang Wang. Emerging advanced approaches for diagnosis and inhibition of liver fibrogenesis. The Egyptian Journal of Internal Medicine 2024; 36(1) doi: 10.1186/s43162-024-00283-y
|
| 10 |
Vasudevan Sekar, Venkateish VP, Vani Vijay, Annapoorna BR, Nivya Vijayan, Madan Kumar Perumal. Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action. Journal of Food Science and Technology 2024; doi: 10.1007/s13197-024-06002-3
|
| 11 |
Aneta Sokal-Dembowska, Sara Jarmakiewicz-Czaja, Katarzyna Ferenc, Rafał Filip. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?. International Journal of Molecular Sciences 2024; 25(10): 5238 doi: 10.3390/ijms25105238
|
| 12 |
Devadoss J. Samuvel, John J. Lemasters, C. James Chou, Zhi Zhong. LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1386238
|